Middle East Pharmaceutical Industries Co. (4016)

• Stock
• Company Profile
• News
• Announcements
• Fair Values
• Corporate Actions
• Earning Announcements
• News Reports
• Major Shareholders
• Volume Statistics
• Financial Ratios
• IPOs
• Financial Statements
• Support and resistance
• More

{{ 'components.chart.period.' + period | translate }}

{{ 'components.chart.type.' + type | translate }}

This mark means that there are news on this date.

Stock

Par Value 10.0 Saudi Riyal

Market Cap 1,308,000,000.00 Saudi Riyal

Book Value (BVPS) 20.87 Saudi Riyal Based on: First Quarter 2026

P/B Ratio 2.90 Last update: 2026-09-11

EPS 5.38 Saudi Riyal Based on: First Quarter 2026

P/E Ratio 11.25 Last update: 2026-09-11

Trading Currency Saudi Riyal

Company Statistics

News

Avalon Pharma extends SAR 50m credit facility deal with Alinma Bank Company News

Avalon Pharma finalizes exclusive licensing deal with China’s Bio-Thera Solutions Companies Investments

Avalon Pharma declares SAR 28m cash dividends for H1-26 Company News

Avalon Pharma’s net profits climb 26% in H1-26 Financial Results

Avalon Pharma appoints new leadership team Board of Directors

CMA greenlights Avalon Pharma’s capital hike Corporate Actions

Market Announcements